Clinical relevance of Fas (APO-1/CD95) e
β
Martin C. JΓ€ckel; Christina Mitteldorf; Stefan Schweyer; LΓ szlΓ² FΓΌzesi
π
Article
π
2001
π
John Wiley and Sons
π
English
β 370 KB
## Background: Expression of fas receptors renders tumor cells potentially susceptible to the host immune system. in squamous cell carcinomas of the head and neck, fas has recently been found to be down-regulated in some cases; its prognostic value and correlation with clinicopathologic parameters,